HLAE0101cl.2A

General

Cell Line

hPSCreg name CEBe012-A-1
Cite as:
CEBe012-A-1
Alternative name(s)
HLAE0101cl.2A
Cell line type Human embryonic stem cell (hESC)
Similar lines
CEBe012-A
(SA121)
Last update 12th February 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Novo Nordisk A/S (NOVO)
Owner Novo Nordisk A/S (NOVO)

External Databases

BioSamples SAMEA115287329

General Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases

External Databases (Donor)

BioSamples SAMEA6407438

Ethics

Also have a look at the ethics information for the parental line CEBe012-A .

hESC Derivation

The source cell information can be found in the parental cell line CEBe012-A.

Culture Conditions

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line CEBe012-A .

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Unknown

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
Gene knock-in
15q21.1
15q21.1, exon 1
Disruption of human B2M (beta-2-microglobulin) gene by targeting Exon 1 of the B2M locus. The designed construct contained a cassette with the HLAE0101 gene. This is a biallelic clone.
TALEN
Gene knock-in
16p13.13
16p13.13, exon 2
Disruption of the CIITA (class II major histocompatibility complex transactivator) gene by targeted integration of deoxythymidine kinase (TK) gene in CIITA gene exon 2.
TALEN